Last month, cancer researcher Amit Verma found himself in a bit of a bind. His lab at the Albert Einstein College of Medicine in New York had just received feedback on a new paper about how genes get turned on and off when healthy pancreas cells develop into tumors. The journal’s reviewers asked his team to do some additional experiments, including a type of whole genome sequencing that reveals DNA modification patterns.